|| Print ||
|Articles - June 2010|
|Thursday, May 13, 2010|
Though it's true that Microsoft chairman Bill Gates met Richard Friesner, co-founder of the Portland-based scientific firm Schrödinger, while playing bridge, there's much more to Gates' recent $10 million investment in Schrödinger than a card game.
"That's something we can all smile about," says Shi-Yi Liu, vice president of marketing for Schrödinger, "but I think it's more fair to say that, as people get to know each other, there's a meeting of the minds and shared views about science and technology."
Founded in California in 1990 and relocated to Portland in 1995, Schrödinger specializes in pharmaceutical software that helps researchers simulate testing of drug compounds. The company, which tops the $20 million revenue mark, employs 140 people, including 40 in Portland.
Liu says the infusion, made through Gates' investment arm, Cascade Investment, will primarily help Schrödinger beef up its research and development staff. The end result: more accurate and better-performing software for new drug development.
Though some of the company's scientists are in Portland — along with the accounting, technical and scientific support and quality assurance departments — most research is done in Schrödinger's New York office, closer to scientific advisers and large commercial customers. That's likely to remain unchanged even with Gates' investment.
Because the drug development process can take more than 10 years and sometimes billions of dollars, Liu says there's not a specific drug that can yet be tied directly to Schrödinger. However, various companies have reached milestones in their drug development processes with Schrödinger's technology. Among its more well-known customers: Bayer HealthCare AG.
The Gates investment, Liu says, comes at an opportune time for Schrödinger and will ultimately provide researchers with more powerful tools in their search for new drugs. One such researcher: David Dawson, who is pursuing a cure for cystic fibrosis at Oregon Health & Science University.
"We're really making an investment in scientific research," Liu says. "We have many ambitious goals and we know where additional basic and advanced research efforts are needed. This investment will enable us to start to execute on that."
Thursday, June 26, 2014
BY ERIC FRUTS | OB BLOGGER
Last year, the housing market in Oregon—and the U.S. as a whole—was blasting off. The Case-Shiller index of home prices ended the year 13% higher than at the beginning of the year. But, was last year a blip, or a trend?
Monday, July 14, 2014
BY TERRY "STARBUCKER" ST. MARIE
I really didn’t know that much about angel investing, but I did know a lot about the entrepreneurial spirit.
Thursday, May 29, 2014
BY JESSICA RIDGWAY
How the president of BlueVolt spends his free time.
Monday, July 07, 2014
BY TOM COX | OB BLOGGER
Named after the 2010 experiment by Thomas Ryan, "Robin Sages" are fake social media profiles designed to encourage linking and divulging valuable information.
Friday, May 30, 2014
BY DEBRA RINGOLD | OB GUEST CONTRIBUTOR
Since 1970 the performance of our public education system has steadily deteriorated.
Friday, June 06, 2014
BY KATIE AUSBURGER | OB GUEST CONTRIBUTOR
How to build a hipster-friendly work environment.
Thursday, May 29, 2014
BY JENNIFER MARGULIS
Don Gentry navigates Klamath Basin water rights.
|The Private 150: Bigger But Leaner|
|The Perfect Food|
|Powerlist: Staffing Firms|
|Taxis Uber Alles?|
|Comcast profit rises 15%|
|American fast food chains snagged by food safety scandal in China|
|Washington volcanoes receive more scientific scrutiny|
|Edward Snowden: Racy photos often shared at NSA|
|Forbes Media to sell majority stake|
|FedEx indicted for delivering illegal prescription drugs|
|Microsoft to cut 18,000 jobs|
Vigilant enters a New Year with a new president.
How George Fox has become one of Oregon's largest private universities.
Forest Grove sees growth in the burgeoning food and beverage scene.
Geffen Mesher is saddened to announce the passing of long-time shareholder, Tom “Mike” Anderson, who died on July 10, 2014, from liver disease diagnosed after recent heart surgery. He was 55 years old.
Fifteen Lane Powell attorneys have been named 2014 “Oregon Super Lawyers,” and another five attorneys have been named as “Oregon Rising Stars” by Super Lawyers magazine.
From its first-ever member forum, to upcoming Board elections, the Oregon-based, non-profit health organization is focused on letting members control their healthcare destiny.